EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potassium‐Competitive Acid Blocker‐Associated Gastric Hyperplastic Polyps With Severe Bleeding: A Case Series

Kengo Kasuga, Sakuya Katakai, Megumi Shimizu, Ayaki Isshiki, Shingo Ishihara, Hiroomi Ogawa, Xing Hua Ma, Takashige Masuo, Yoji Takeuchi, Toshio Uraoka

DEN Open · 2026-04 · 6 (1)

DOI: 10.1002/deo2.70326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DEN Open, online erschienen am 14.04.2026. Verfasst von Kengo Kasuga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology Isesaki Municipal Hospital Gunma Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric hyperplastic polyps can cause gastrointestinal bleeding, and their enlargement has been associated with long‐term acid‐suppressive therapy. Vonoprazan (VPZ), a potassium‐competitive acid blocker, provides potent acid suppression and may induce hypergastrinemia, potentially contributing to the growth of hyperplastic polyps. However, clinical information regarding VPZ‐associated gastric hyperplastic polyps remains limited. We report three cases of severe bleeding from gastric hyperplastic polyps in patients who were administered VPZ. Case 1 involved a 92‐year‐old woman who presented with melena and anemia. Endoscopy revealed an 8‐cm hyperplastic polyp, and although resection was considered, it was deferred. After switching from VPZ to an H2‐receptor antagonist (H2RA), her anemia gradually improved, and the polyp regressed. Case 2 involved a 61‐year‐old man with hematemesis due to bleeding from multiple hyperplastic polyps. Emergency endoscopic mucosal resection was performed, and markedly elevated serum gastrin levels were noted. Following the replacement of VPZ with an H2RA, the size of the remaining polyps decreased. Case 3 involved a 54‐year‐old man with anemia and recurrent bleeding from hyperplastic polyps, requiring multiple endoscopic treatments. After VPZ discontinuation and H2RA initiation, the unresected polyps regressed. Two patients were undergoing hemodialysis, which may have exacerbated hypergastrinemia and bleeding. In all three cases, switching from VPZ to an H2RA resulted in the regression of gastric hyperplastic polyps and improvement of anemia. In patients receiving VPZ who develop progressive anemia or bleeding from hyperplastic polyps, discontinuation of VPZ or switching to an H2RA may be effective.

Schlagwörter

Stichwörter der Autor:innen

Vonoprazanacid suppression therapygastrointestinal hemorrhagehistamine H2 antagonistshypergastrinemia

Autor:innen und Institutionen

  • Department of Gastroenterology Isesaki Municipal Hospital Gunma Japan.
  • Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Gunma Japan.
  • Department of Surgery Isesaki Municipal Hospital Gunma Japan.

Zitieren

APA

Kasuga, K., Katakai, S., Shimizu, M., Isshiki, A., Ishihara, S., Ogawa, H., Ma, X. H., Masuo, T., Takeuchi, Y., & Uraoka, T. (2026). Potassium‐Competitive Acid Blocker‐Associated Gastric Hyperplastic Polyps With Severe Bleeding: A Case Series. DEN Open, 6(1). https://doi.org/10.1002/deo2.70326

Vancouver

Kasuga K, Katakai S, Shimizu M, Isshiki A, Ishihara S, Ogawa H, et al. Potassium‐Competitive Acid Blocker‐Associated Gastric Hyperplastic Polyps With Severe Bleeding: A Case Series. DEN Open. 2026;6(1). doi:10.1002/deo2.70326

BibTeX
@article{Kasuga2026,
  author = {Kasuga, Kengo and Katakai, Sakuya and Shimizu, Megumi and Isshiki, Ayaki and Ishihara, Shingo and Ogawa, Hiroomi and Ma, Xing Hua and Masuo, Takashige and Takeuchi, Yoji and Uraoka, Toshio},
  title = {Potassium‐Competitive Acid Blocker‐Associated Gastric Hyperplastic Polyps With Severe Bleeding: A Case Series},
  journal = {DEN Open},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1002/deo2.70326}
}
Kostenlos starten →